Palla Pharma Ltd
ASX:PAL
Palla Pharma Ltd
ASX:PAL
Price:
0.295 AUD
Market Closed
Updated:
Apr 30, 2024
Palla Pharma Ltd
Cash from Financing Activities
|
Palla Pharma Ltd
Cash from Financing Activities Peer Comparison
Comparables:
ADO
PIQ
CTE
GSS
E
EZZ
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
Palla Pharma Ltd
ASX:PAL
|
Cash from Financing Activities
AU$19.1m
|
CAGR 3-Years
-4%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
|
Anteotech Ltd
ASX:ADO
|
Cash from Financing Activities
AU$1.4m
|
CAGR 3-Years
-37%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-12%
|
|
|
Proteomics International Laboratories Ltd
ASX:PIQ
|
Cash from Financing Activities
AU$3.8m
|
CAGR 3-Years
-12%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
Cryosite Ltd
ASX:CTE
|
Cash from Financing Activities
-AU$809.8k
|
CAGR 3-Years
-40%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
-3%
|
|
|
Genetic Signatures Ltd
ASX:GSS
|
Cash from Financing Activities
AU$7.5m
|
CAGR 3-Years
90%
|
CAGR 5-Years
172%
|
CAGR 10-Years
N/A
|
|
E
|
EZZ Life Science Holdings Ltd
ASX:EZZ
|
Cash from Financing Activities
-AU$761.7k
|
CAGR 3-Years
-84%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Palla Pharma Ltd's Cash from Financing Activities?
Cash from Financing Activities
19.1m
AUD
19.1m
AUD
Based on the financial report for Jun 30, 2021, Palla Pharma Ltd's Cash from Financing Activities amounts to 19.1m AUD.
What is Palla Pharma Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
2%
2%
Over the last year, the Cash from Financing Activities growth was 76%. The average annual Cash from Financing Activities growth rates for Palla Pharma Ltd have been -4% over the past three years , 2% over the past five years .
You don't have any saved screeners yet
